世界の人工呼吸器市場(~2026年):モビリティ別(集中治療用、携帯型)、種類別、モード別(風量、圧力、複合)、インターフェース別(侵襲性、非侵襲性)、エンドユーザー別(病院、クリニック、在宅医療、ACC、救急医療サービス)、地域別

【英語タイトル】Ventilators Market by Mobility (Intensive Care, Portable), Type, Mode (Volume, Pressure, Combined), Interface (Invasive, Non-invasive), End-User (Hospital, Clinic, Home Care, ACC, Emergency Medical Services), Region - Global Forecast to 2026

MarketsandMarketsが出版した調査資料(MD4529)・商品コード:MD4529
・発行会社(調査会社):MarketsandMarkets
・発行日:2022年2月3日
・ページ数:260
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License(法人閲覧)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

マーケッツアンドマーケッツ社は、世界の人工呼吸器市場規模が、2021年14億ドルから2026年19億ドルまで年平均7.6%成長すると予測しています。本調査レポートは、人工呼吸器の世界市場について広く調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、産業インサイト、モビリティ別(集中治療用、可搬/移動型)分析、種類別(成人/小児用、新生児/乳児用)分析、インターフェース別(侵襲性、非侵襲性)分析、エンドユーザー別(病院・クリニック、外来治療センター、救急医療サービス、在宅医療)分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・産業インサイト
・世界の人工呼吸器市場規模:モビリティ別(集中治療用、可搬/移動型)
・世界の人工呼吸器市場規模:種類別(成人/小児用、新生児/乳児用)
・世界の人工呼吸器市場規模:インターフェース別(侵襲性、非侵襲性)
・世界の人工呼吸器市場規模:エンドユーザー別(病院・クリニック、外来治療センター、救急医療サービス、在宅医療)
・世界の人工呼吸器市場規模:地域別
・競争状況
・企業情報

“The ventilators market is projected to reach USD 1.9 billion in 2026 from USD 1.4 billion in 2021, at a CAGR of 7.6% during the forecast period.”
A ventilator, breathing machine, or respirator is a machine that assists with breathing. It is mainly used in hospitals to treat chronic obstructive pulmonary disease (COPD), sleep apnea, acute lung injury, and hypoxemia. Over the years, the ventilators market has evolved significantly due to technological advancements, such as developing advanced portable ventilators and improvements in the sensor technologies used in ventilators. The increasing number of preterm births, rapid growth in the geriatric population, rising prevalence of respiratory diseases, rising number of ICU beds, and rising number of COVID-19 patients are expected to drive growth in the ventilators market during the forecast period. The emergence of home healthcare has opened new avenues for the ventilators market. Convenience and comfort in the home care environment, coupled with cost advantages, are the other major factors driving growth in the home healthcare market for ventilators.

“The intensive care segment is expected to account for the largest share of the ventilators market”
The intensive care segment accounted for the largest share of the global ventilators market in 2020. The large share of the intensive care ventilators segment can be attributed to the rising number of intensive care beds equipped with ventilators. Increasing ICU admissions due to COVID-19 and re-admissions in developed countries, coupled with appropriate reimbursements, are also responsible for the large share of the ICU ventilators segment.

“The adult/pediatric ventilators segment is expected to account for the largest share of the ventilators market”
The adult/pediatric ventilators segment accounted for the largest share of the ventilators market in 2020. The large share of the adult/pediatric ventilators segment can be attributed to the large adult population suffering from COVID-19, the growing incidence of chronic diseases such as COPD & asthma, the growing number of smokers, and the rising geriatric population.

“The invasive ventilation segment is expected to account for the largest share of the ventilators market”
The invasive ventilation segment accounted for the largest share of the ventilators market in 2020. Growth in the invasive ventilation market can be attributed to the increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.

“Combined-mode ventilation segment is expected to account for the largest share of the ventilators market”
The combined-mode ventilation segment accounted for the largest share of the ventilators market in 2020. The large share of this segment can be attributed to its advantages over conventional pressure-mode ventilation and volume-mode ventilation. The ability of combined-mode ventilation to provide both modes of ventilation makes it a desirable product in the ventilators market.

“Hospitals & clinics segment holds the highest market share in the ventilators market”
The hospitals & clinics segment is likely to dominate the ventilators market during the forecast period is attributed to the financial capabilities of hospitals to purchase high-priced instruments and the availability of trained professionals to operate ventilators. Market growth is also driven by the rapidly increasing incidence of coronavirus disease. The COVID-19 outbreak has not only created pressure on healthcare resources but has also increased the number of hospital admissions.

“North America to dominate the ventilators market during the forecast period”
The ventilators market in North America dominated the ventilators market in the forecast period. The rising geriatric population, growing number of smokers, high prevalence of respiratory diseases, increasing COVID-19 patient volumes, highly developed healthcare system, high healthcare expenditure, and major market players in the US are the key factors driving the ventilators market in North America.

A breakdown of the primary participants for the ventilators marketreferred to for this report is provided below:
• By Company Type: Tier 1–34%, Tier 2–38%, and Tier 3–28%
• By Designation: C-level–26%, Director Level–35%, and Others–39%
• By Region: North America–17%, Europe–39%, Asia Pacific–28%,Latin America- 8%, Middle East & Africa-8%

The prominent players in the ventilators market include Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), Smiths Group plc (UK), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Avasarala Technologies Ltd (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Engineering Pvt. Ltd. (Argentina).

Research Coverage:
The report analyzes the market for various ventilatorsand their adoption pattern. It aims at estimating the market size and future growth potential of the global ventilators marketand different segments such asmobility, type, interface, mode, end user, and region.The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product& service offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening theirmarket presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global ventilatorsmarket
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities,and product or service launches in the global ventilatorsmarket
• Market Development: Comprehensive information on the lucrative emerging regionsbyproduct, application, end user,and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in theglobal ventilators market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis,and products& services of leading players in theglobal ventilators market.

❖ レポートの目次 ❖

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 VENTILATORS MARKET SEGMENTATION 34
FIGURE 2 VENTILATORS MARKET, BY REGION 34
1.4 YEARS CONSIDERED 35
1.5 CURRENCY 35
TABLE 1 STANDARD CURRENCY CONVERSION RATES 35
1.6 LIMITATIONS 36
1.7 STAKEHOLDERS 36
1.8 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 4 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS:
SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (VENTILATORS MARKET) 42
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 43
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 44
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 45
FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: VENTILATORS MARKET (2020) 46
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR THE VENTILATORS MARKET (2021–2026) 47
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 13 TOP-DOWN APPROACH 48

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 50
FIGURE 14 DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ESTIMATION 51
2.5 STUDY ASSUMPTIONS 51
2.6 LIMITATIONS 51
2.6.1 METHODOLOGY-RELATED LIMITATIONS 52
2.7 RISK ASSESSMENT 52
TABLE 2 RISK ASSESSMENT: VENTILATORS MARKET 52
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VENTILATORS MARKET 52
3 EXECUTIVE SUMMARY 54
FIGURE 15 VENTILATORS MARKET, BY MOBILITY, 2021 VS. 2026 (USD MILLION) 54
FIGURE 16 VENTILATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2021 VS. 2026 (USD MILLION) 55
FIGURE 18 VENTILATORS MARKET, BY MODE, 2021 VS. 2026 (USD MILLION) 56
FIGURE 19 VENTILATORS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 56
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF THE VENTILATORS MARKET 57
4 PREMIUM INSIGHTS 58
4.1 VENTILATORS MARKET OVERVIEW 58
FIGURE 21 COVID-19 PANDEMIC AND GROWTH IN THE PREVALENCE OF CHRONIC RESPIRATORY DISEASES ARE DRIVING THE GROWTH OF THE VENTILATORS MARKET 58
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY & COUNTRY (2020) 59
FIGURE 22 INTENSIVE CARE VENTILATORS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC VENTILATORS MARKET IN 2020 59
4.3 VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 23 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 60
4.4 VENTILATORS MARKET: REGIONAL MIX 60
FIGURE 24 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2026 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 25 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 High prevalence of respiratory diseases 62
5.2.1.1.1 High prevalence of COPD and asthma 62
5.2.1.1.2 High prevalence of tobacco smoking 62
TABLE 3 PREVALENCE AND DEATHS CAUSED DUE TO SMOKING 63
5.2.1.2 Rapid growth in the global geriatric population 63
FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 63
5.2.1.3 Government initiatives toward increasing the availability of ventilators amidst the COVID-19 pandemic 63
5.2.1.4 Increasing number of patients transferred to intensive care units 64
5.2.1.5 Outbreak of the COVID-19 pandemic 64
5.2.1.6 Growing preference for home-based oxygen therapy 64
5.2.2 RESTRAINTS 64
5.2.2.1 Dearth of skilled medical workers 64
5.2.2.2 Over purchase of ventilators in hospitals 65
5.2.2.3 Reimbursement concerns 65
5.2.3 OPPORTUNITIES 65
5.2.3.1 Development of non-invasive and microprocessor-controlled portable ventilators 65
5.2.3.2 Growth in healthcare spending 66
TABLE 4 TOTAL HEALTH EXPENDITURE PER CAPITA IN PURCHASING
POWER PARITY (USD) 66
5.2.3.3 Cost advantages of home care services 66
5.2.3.4 Growth opportunities in emerging countries 66
5.2.4 CHALLENGES 67
5.2.4.1 Low awareness and a large population of undiagnosed & undertreated patients 67
5.2.4.2 Harmful effects of certain devices on neonates 67
6 INDUSTRY INSIGHTS 68
6.1 TECHNOLOGY ANALYSIS 68
6.1.1 ARTIFICIAL INTELLIGENCE IN THE VENTILATORS MARKET 68
6.1.1.1 Introduction 68
6.1.1.2 The future of healthcare—Big Data and artificial intelligence 68
6.1.1.3 Knowledge-based systems for ventilation management 69
FIGURE 27 AI INTEGRATION INTO VENTILATORS 69
6.1.1.4 COVID-19 to drive the demand for artificial intelligence in ventilators 69
6.1.2 SENSOR TECHNOLOGIES IN VENTILATORS 70
6.1.2.1 Introduction 70
6.1.2.2 Flow sensors 70
6.1.2.3 Oxygen sensors 71
6.1.2.4 Pressure sensors 71
6.1.3 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL 72
6.1.3.1 E-Nose technology 72
6.1.3.2 MEMS technology 72
6.1.3.3 Electrochemical technology 72
6.1.3.4 Paramagnetic technology 73
6.1.3.5 Wireless gas sensor technology 73

6.2 INDUSTRY TRENDS 73
TABLE 5 MARKET CONSOLIDATION AND THE RISING DEMAND FOR PORTABLE VENTILATORS ARE THE MAJOR TRENDS IN THE MARKET 73
6.2.1 RISING DEMAND FOR ENHANCED PORTABLE AND COMPACT VENTILATORS 74
6.2.2 CONSOLIDATION OF THE MARKET 74
FIGURE 28 RECENT ACQUISITIONS IN THE MARKET 74
6.2.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 75
6.2.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATION 75
6.2.5 NON-MEDICAL COMPANIES ENTERING THE MARKET TO CATER TO THE INCREASING DEMAND FOR VENTILATORS 75
6.3 FACTOR ANALYSIS 76
6.3.1 POPULATION SCENARIO 76
FIGURE 29 TOTAL POPULATION, BY COUNTRY/REGION 76
FIGURE 30 URBAN POPULATION, BY COUNTRY/REGION 76
FIGURE 31 GERIATRIC POPULATION (AGED ABOVE 65 YEARS) 77
6.3.2 HEALTHCARE EXPENDITURE 78
FIGURE 32 THE US ACCOUNTED FOR THE HIGHEST HEALTHCARE
EXPENDITURE (% OF GDP) 78
6.3.3 TARGET POPULATION 79
FIGURE 33 COVID-19 POPULATION: TOTAL POPULATION VS. RECOVERED POPULATION 79
6.4 PRICING ANALYSIS 79
TABLE 6 AVERAGE SELLING PRICE OF VENTILATORS OFFERED BY TOP PLAYERS 79
6.5 VALUE CHAIN ANALYSIS 80
FIGURE 34 VALUE CHAIN: VENTILATORS MARKET 81
6.6 ECOSYSTEM MAPPING 81
FIGURE 35 VENTILATORS MARKET: ECOSYSTEM ANALYSIS 82
6.7 SUPPLY CHAIN ANALYSIS 82
6.8 PORTER’S FIVE FORCES ANALYSIS 84
TABLE 7 PORTER’S FIVE FORCES ANALYSIS 84
6.8.1 THREAT OF NEW ENTRANTS 84
6.8.2 THREAT OF SUBSTITUTES 85
6.8.3 BARGAINING POWER OF SUPPLIERS 85
6.8.4 BARGAINING POWER OF BUYERS 85
6.8.5 INTENSITY OF COMPETITIVE RIVALRY 85
6.9 REGULATORY ANALYSIS 86
6.9.1 NORTH AMERICA 86
6.9.1.1 US 86
6.9.1.2 Canada 86
6.9.2 EUROPE 86
6.9.3 ASIA PACIFIC 86
6.9.3.1 Japan 86
6.9.3.2 China 87
6.9.3.3 India 87
6.10 PATENT ANALYSIS 87
6.10.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 87
FIGURE 37 GLOBAL PATENT PUBLICATION TRENDS IN THE VENTILATORS MARKET, 2015–2020 88
6.10.2 TOP APPLICANTS (COMPANIES) OF VENTILATOR PATENTS 88
FIGURE 38 TOP COMPANIES THAT APPLIED FOR VENTILATOR PATENTS, 2015–2020 88
6.10.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE VENTILATORS MARKET 89
FIGURE 39 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR VENTILATOR PATENTS, 2015–2020 89
6.11 TRADE ANALYSIS 89
TABLE 8 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY 89
6.12 CASE STUDY ANALYSIS 90
TABLE 9 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. DEVELOPING ECONOMIES 90
TABLE 10 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS 91
6.13 IMPACT OF COVID-19 ON THE VENTILATORS MARKET 91
7 VENTILATORS MARKET, BY MOBILITY 92
7.1 INTRODUCTION 93
TABLE 11 VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 93
7.2 INTENSIVE CARE VENTILATORS 93
TABLE 12 MAJOR PRODUCTS: ICU VENTILATORS 94
TABLE 13 INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 95
TABLE 14 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 15 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 96
7.2.1 HIGH-END ICU VENTILATORS 96
7.2.1.1 Improving healthcare infrastructure and rising healthcare expenditure in developing countries to drive market growth 96
TABLE 16 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 17 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 98
7.2.2 MID-END ICU VENTILATORS 98
7.2.2.1 Mid-end ICU ventilators are in high demand owing to the
COVID-19 pandemic 98
TABLE 18 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 19 MID-END ICU VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 100
7.2.3 BASIC ICU VENTILATORS 100
7.2.3.1 Basic ICU ventilators are equipped with minimal features as compared to high-end and mid-end ICU ventilators 100
TABLE 20 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 21 BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2019–2026 (UNITS) 102
7.3 PORTABLE/TRANSPORTABLE VENTILATORS 102
7.3.1 LOW WEIGHT AND ROBUST NATURE HAVE INCREASED THE DEMAND FOR PORTABLE/TRANSPORTABLE VENTILATORS 102
TABLE 22 MAJOR PRODUCTS: PORTABLE/TRANSPORTABLE VENTILATORS 103
TABLE 23 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 24 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,
2019–2026 (UNITS) 105
8 VENTILATORS MARKET, BY TYPE 106
8.1 INTRODUCTION 107
TABLE 25 VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
8.2 ADULT/PEDIATRIC VENTILATORS 107
8.2.1 INCREASING NUMBER OF COVID-19 CASES AMONG ADULTS DRIVING THE DEMAND FOR ADULT VENTILATORS 107
TABLE 26 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
8.3 NEONATAL/INFANT VENTILATORS 108
8.3.1 NEW TECHNOLOGIES AND INNOVATIONS IN THE FIELD OF NEONATAL VENTILATORS TO DRIVE MARKET GROWTH 108
TABLE 27 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
9 VENTILATORS MARKET, BY INTERFACE 110
9.1 INTRODUCTION 111
TABLE 28 VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 111
9.2 INVASIVE VENTILATION 111
9.2.1 INCREASING CASES OF COVID-19 AND RISING PREVALENCE OF RESPIRATORY DISEASES TO SUPPORT MARKET GROWTH 111
TABLE 29 INVASIVE VENTILATION MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
9.3 NON-INVASIVE VENTILATION 112
9.3.1 INCREASING ADOPTION OF NON-INVASIVE VENTILATION AMONG END USERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 112
TABLE 30 NON-INVASIVE VENTILATION MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 113
10 VENTILATORS MARKET, BY END USER 114
10.1 INTRODUCTION 115
TABLE 31 VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 115
10.2 HOSPITALS & CLINICS 115
10.2.1 GROWING PATIENT VOLUMES DUE TO COVID-19 TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 115
TABLE 32 VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2019–2026 (USD MILLION) 116

10.3 AMBULATORY CARE CENTERS 116
10.3.1 GROWING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH IN THIS
END-USER SEGMENT 116
TABLE 33 VENTILATORS MARKET FOR AMBULATORY CARE CENTERS,
BY COUNTRY, 2019–2026 (USD MILLION) 117
10.4 EMERGENCY MEDICAL SERVICES 118
10.4.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 34 VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 118
10.5 HOME CARE SETTINGS 119
10.5.1 HOME CARE VENTILATORS ARE CONVENIENT AND CAN BE USED IN THE COMFORT OF THE PATIENT’S HOME—KEY FACTORS DRIVING MARKET GROWTH 119
TABLE 35 VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2019–2026 (USD MILLION) 120
11 VENTILATORS MARKET, BY REGION 121
11.1 INTRODUCTION 122
FIGURE 40 CHINA TO REGISTER THE HIGHEST GROWTH RATE IN THE VENTILATORS MARKET DURING THE FORECAST PERIOD 122
TABLE 36 VENTILATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
11.2 NORTH AMERICA 123
FIGURE 41 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 124
TABLE 37 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 38 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 125
TABLE 39 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 40 NORTH AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 41 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 126
TABLE 42 NORTH AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 126
TABLE 43 NORTH AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 126
11.2.1 US 127
11.2.1.1 The US dominated the North American ventilators market in 2020 127
TABLE 44 US: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 127
TABLE 45 US: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 128
TABLE 46 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 47 US: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 128
TABLE 48 US: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 128
TABLE 49 US: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 129
TABLE 50 US: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 129
11.2.2 CANADA 129
11.2.2.1 Increasing incidence of COPD is driving the adoption of ventilators in Canada 129
TABLE 51 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 130
TABLE 52 CANADA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 130
TABLE 53 CANADA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 131
TABLE 54 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 55 CANADA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 56 CANADA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 132
TABLE 57 CANADA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 132
TABLE 58 CANADA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 132
11.3 EUROPE 133
FIGURE 42 EUROPE: VENTILATORS MARKET SNAPSHOT 134
TABLE 59 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 60 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 135
TABLE 61 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 62 EUROPE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 63 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 136
TABLE 64 EUROPE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 136
TABLE 65 EUROPE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 137
11.3.1 GERMANY 137
11.3.1.1 Germany dominated the ventilators market in Europe in 2019 137
TABLE 66 GERMANY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 137
TABLE 67 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 138
TABLE 68 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 69 GERMANY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 70 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 138
TABLE 71 GERMANY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 139
TABLE 72 GERMANY: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 139
11.3.2 FRANCE 139
11.3.2.1 The highly advanced and well-established healthcare system in France driving market growth 139
TABLE 73 FRANCE: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 140
TABLE 74 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 140
TABLE 75 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 140
TABLE 76 FRANCE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 77 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 141
TABLE 78 FRANCE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 141
TABLE 79 FRANCE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 142
11.3.3 UK 142
11.3.3.1 Increasing healthcare expenditure is driving the growth of the ventilators market in the country 142
TABLE 80 UK: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 143
TABLE 81 UK: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 143
TABLE 82 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 143
TABLE 83 UK: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 84 UK: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 144
TABLE 85 UK: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 144
TABLE 86 UK: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 145
11.3.4 ITALY 145
11.3.4.1 Presence of a well-developed healthcare system in the country and rapid growth in the aging population to drive market growth 145
TABLE 87 ITALY: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 146
TABLE 88 ITALY: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 146
TABLE 89 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 146
TABLE 90 ITALY: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 91 ITALY: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 147
TABLE 92 ITALY: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 147
TABLE 93 ITALY: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 148
11.3.5 SPAIN 148
11.3.5.1 Increasing geriatric population to drive market growth in Spain 148
TABLE 94 SPAIN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 148
TABLE 95 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 149
TABLE 96 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 97 SPAIN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 98 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 150
TABLE 99 SPAIN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 150
TABLE 100 SPAIN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 150
11.3.6 NETHERLANDS 151
11.3.6.1 Increasing patient population to support market growth in the Netherlands 151
TABLE 101 NETHERLANDS: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 151
TABLE 102 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 151
TABLE 103 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 152
TABLE 104 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 105 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 152
TABLE 106 NETHERLANDS: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 153
TABLE 107 NETHERLANDS: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 153
11.3.7 REST OF EUROPE 153
TABLE 108 ROE: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 154
TABLE 109 ROE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 110 ROE: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 111 ROE: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 155
TABLE 112 ROE: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 155
TABLE 113 ROE: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 155
11.4 ASIA PACIFIC 156
FIGURE 43 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 157
TABLE 114 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 158
TABLE 115 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 158
TABLE 116 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 117 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 118 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 159
TABLE 119 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 159
TABLE 120 ASIA PACIFIC: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 160
11.4.1 JAPAN 160
11.4.1.1 Japan’s established healthcare system to support market growth during the forecast period 160
TABLE 121 JAPAN: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 161
TABLE 122 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 161
TABLE 123 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 161
TABLE 124 JAPAN: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 125 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 162
TABLE 126 JAPAN: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 162
TABLE 127 JAPAN: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 163
11.4.2 CHINA 163
11.4.2.1 Healthcare development and initiatives to curb COVID-19 to stimulate the market growth for ventilators in China 163
TABLE 128 CHINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 164
TABLE 129 CHINA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 164
TABLE 130 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 131 CHINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 132 CHINA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 165
TABLE 133 CHINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 165
TABLE 134 CHINA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 166
11.4.3 INDIA 166
11.4.3.1 Increasing COVID-19 patient volume to drive the ventilators market in India 166
TABLE 135 INDIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 167
TABLE 136 INDIA: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 167
TABLE 137 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 138 INDIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 139 INDIA: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 168
TABLE 140 INDIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 168
TABLE 141 INDIA: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 169
11.4.4 AUSTRALIA 169
11.4.4.1 High prevalence of chronic diseases to drive the demand for ventilators in Australia during the forecast period 169
TABLE 142 AUSTRALIA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 170
TABLE 143 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 170
TABLE 144 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 145 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 146 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 171
TABLE 147 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 171
TABLE 148 AUSTRALIA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 172
11.4.5 REST OF ASIA PACIFIC 172
TABLE 149 ROAPAC: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 172
TABLE 150 ROAPAC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 151 ROAPAC: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 152 ROAPAC: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 173
TABLE 153 ROAPAC: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 174
TABLE 154 ROAPAC: VENTILATORS MARKET, BY END USER,2019–2026 (USD MILLION) 174
11.5 LATIN AMERICA 174
TABLE 155 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 175
TABLE 156 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 175
TABLE 157 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 158 LATIN AMERICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 159 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 176
TABLE 160 LATIN AMERICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 176
TABLE 161 LATIN AMERICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 177
11.5.1 BRAZIL 177
11.5.1.1 Healthcare infrastructure improvement to support market growth in Brazil 177
TABLE 162 BRAZIL: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 178
TABLE 163 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 178
TABLE 164 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 165 BRAZIL: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 166 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 82019–2026 (USD MILLION) 179
TABLE 167 BRAZIL: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 179
TABLE 168 BRAZIL: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 180
11.5.2 MEXICO 180
11.5.2.1 Rising obesity rate to increase the incidence rate of respiratory diseases in Mexico 180
TABLE 169 MEXICO: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 181
TABLE 170 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 181
TABLE 171 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 172 MEXICO: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 173 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2019–2026 (USD MILLION) 182
TABLE 174 MEXICO: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 182
TABLE 175 MEXICO: VENTILATORS MARKET, BY END USER, 2019–2026 (USD MILLION) 183
11.5.3 ARGENTINA 183
11.5.3.1 Rising prevalence of respiratory diseases in Argentina to drive market growth 183
TABLE 176 ARGENTINA: KEY MACROINDICATORS FOR THE VENTILATORS MARKET 183
TABLE 177 ARGENTINA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 184
TABLE 178 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 179 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 180 ARGENTINA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 185
TABLE 181 ARGENTINA: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 185
TABLE 182 ARGENTINA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 185
11.5.4 REST OF LATIN AMERICA 186
TABLE 183 ROLATAM: VENTILATORS MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 186
TABLE 184 ROLATAM: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 185 ROLATAM: VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 186 ROLATAM: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 187
TABLE 187 ROLATAM: VENTILATORS MARKET, BY MODE, 2019–2026 (USD MILLION) 187
TABLE 188 ROLATAM: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 187
11.6 MIDDLE EAST & AFRICA 188
11.6.1 GROWING GERIATRIC POPULATION TO DRIVE GROWTH IN THE MIDDLE EAST & AFRICA 188
TABLE 189 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 188
TABLE 190 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 191 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 189
TABLE 192 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE,
2019–2026 (USD MILLION) 189
TABLE 193 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE,
2019–2026 (USD MILLION) 190
TABLE 194 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY END USER,
2019–2026 (USD MILLION) 190
12 COMPETITIVE LANDSCAPE 191
12.1 INTRODUCTION 191
TABLE 195 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO JANUARY 2022) 191
12.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 192
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN VENTILATORS MARKET 192
12.3 MARKET SHARE ANALYSIS 192
FIGURE 45 VENTILATORS MARKET SHARE, BY KEY PLAYER, 2020 193
12.4 COMPETITIVE SCENARIO 194
12.4.1 PRODUCT LAUNCHES 194
TABLE 196 VENTILATORS MARKET: SERVICE LAUNCHES
(JANUARY 2018 TO JANUARY 2022) 194
12.4.2 DEALS 195
TABLE 197 VENTILATORS MARKET: DEALS (JANUARY 2018 TO JANUARY 2022) 195
12.4.3 OTHER DEVELOPMENTS 196
TABLE 198 VENTILATORS MARKET: OTHER DEVELOPMENTS
(JANUARY 2018 TO JANUARY 2022) 196
12.5 COMPETITIVE BENCHMARKING 197
12.5.1 FOOTPRINT OF KEY PLAYERS IN THE VENTILATORS MARKET 197
12.5.2 MOBILITY FOOTPRINT OF COMPANIES 198
12.5.3 TYPE FOOTPRINT OF COMPANIES 199
12.5.4 INTERFACE FOOTPRINT OF COMPANIES 200
12.5.5 MODE FOOTPRINT OF COMPANIES 201
12.5.6 END-USER FOOTPRINT OF COMPANIES 202
12.5.7 REGIONAL FOOTPRINT OF COMPANIES 203
FIGURE 46 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN VENTILATORS MARKET 204
12.6 VENTILATORS MARKET: R&D EXPENDITURE 205
FIGURE 47 R&D EXPENDITURE OF KEY PLAYERS IN THE VENTILATORS MARKET (2019 VS. 2020) 205
12.7 COMPANY EVALUATION MATRIX 205
12.7.1 STARS 206
12.7.2 EMERGING LEADERS 206
12.7.3 PERVASIVE PLAYERS 206
12.7.4 EMERGING COMPANIES 206
FIGURE 48 VENTILATORS MARKET: GLOBAL COMPANY EVALUATION MATRIX 207
12.8 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 207
12.8.1 PROGRESSIVE COMPANIES 207
12.8.2 STARTING BLOCKS 208
12.8.3 RESPONSIVE COMPANIES 208
12.8.4 DYNAMIC COMPANIES 208
FIGURE 49 VENTILATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS 208
13 COMPANY PROFILES 209
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 KEY PLAYERS 209
13.1.1 KONINKLIJKE PHILIPS N.V. 209
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 209
FIGURE 50 COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V. (2020) 210
13.1.2 RESMED 213
TABLE 200 RESMED INC.: BUSINESS OVERVIEW 213
FIGURE 51 COMPANY SNAPSHOT: RESMED (2020) 214
13.1.3 MEDTRONIC 217
TABLE 201 MEDTRONIC: BUSINESS OVERVIEW 217
FIGURE 52 COMPANY SNAPSHOT: MEDTRONIC (2020) 218
13.1.4 VYAIRE MEDICAL, INC. 221
TABLE 202 VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW 221
13.1.5 GETINGE AB 224
TABLE 203 GETINGE AB: BUSINESS OVERVIEW 224
FIGURE 53 COMPANY SNAPSHOT: GETINGE AB (2020) 225
13.1.6 DRÄGERWERK AG & CO. KGAA 228
TABLE 204 DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW 228
FIGURE 54 COMPANY SNAPSHOT: DRÄGERWERK AG & CO. KGAA (2020) 228
13.1.7 SMITHS GROUP PLC 231
TABLE 205 SMITHS GROUP PLC: BUSINESS OVERVIEW 231
FIGURE 55 COMPANY SNAPSHOT: SMITHS GROUP PLC (2020) 232
13.1.8 HAMILTON MEDICAL 234
TABLE 206 HAMILTON MEDICAL: BUSINESS OVERVIEW 234
13.1.9 GE HEALTHCARE 236
TABLE 207 GE HEALTHCARE: BUSINESS OVERVIEW 236
FIGURE 56 COMPANY SNAPSHOT: GE HEALTHCARE (2020) 237
13.1.10 FISHER & PAYKEL HEALTHCARE LIMITED 239
TABLE 208 FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW 239
FIGURE 57 COMPANY SNAPSHOT: FISHER & PAYKEL HEALTHCARE LIMITED (2020) 240
13.2 OTHER PLAYERS 242
13.2.1 AIR LIQUIDE 242
TABLE 209 AIR LIQUIDE: BUSINESS OVERVIEW 242
FIGURE 58 COMPANY SNAPSHOT: AIR LIQUIDE (2020) 243
13.2.2 ASAHI KASEI CORPORATION 245
TABLE 210 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 245
FIGURE 59 COMPANY SNAPSHOT: ASAHI KASEI CORPORATION (2020) 246
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC. 248
TABLE 211 ALLIED HEALTH PRODUCTS, INC.: BUSINESS OVERVIEW 248
FIGURE 60 COMPANY SNAPSHOT: ALLIED HEALTH PRODUCTS, INC. (2020) 248
13.2.4 NIHON KOHDEN CORPORATION 250
TABLE 212 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 250
FIGURE 61 COMPANY SNAPSHOT: NIHON KOHDEN CORPORATION (2020) 251
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 253
13.2.6 AXCENT MEDICAL GMBH 253
13.2.7 METRAN CO., LTD. 254
13.2.8 MAGNAMED 254
13.2.9 LEISTUNG ENGINEERING PVT. LTD. 255
13.2.10 AVASARALA TECHNOLOGIES LIMITED 255
13.2.11 AIRON CORPORATION 256
13.2.12 TRITON ELECTRONIC SYSTEMS LTD. 256
13.2.13 HILL-ROM HOLDINGS, INC. 257
13.2.14 BIO-MED DEVICES, INC. 257
13.2.15 HEYER MEDICAL AG 258
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 259
14.1 DISCUSSION GUIDE 259
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
14.3 AVAILABLE CUSTOMIZATIONS 266
14.4 RELATED REPORTS 266
14.5 AUTHOR DETAILS 267



★調査レポート[世界の人工呼吸器市場(~2026年):モビリティ別(集中治療用、携帯型)、種類別、モード別(風量、圧力、複合)、インターフェース別(侵襲性、非侵襲性)、エンドユーザー別(病院、クリニック、在宅医療、ACC、救急医療サービス)、地域別] (コード:MD4529)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の人工呼吸器市場(~2026年):モビリティ別(集中治療用、携帯型)、種類別、モード別(風量、圧力、複合)、インターフェース別(侵襲性、非侵襲性)、エンドユーザー別(病院、クリニック、在宅医療、ACC、救急医療サービス)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆